166 related articles for article (PubMed ID: 30718378)
1. Somatic recombination underlies frequent revertant mosaicism in loricrin keratoderma.
Suzuki S; Nomura T; Miyauchi T; Takeda M; Fujita Y; Nishie W; Akiyama M; Ishida-Yamamoto A; Shimizu H
Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718378
[TBL] [Abstract][Full Text] [Related]
2. Recombination-induced revertant mosaicism in ichthyosis with confetti and loricrin keratoderma.
Nomura T
J Dermatol Sci; 2020 Feb; 97(2):94-100. PubMed ID: 31928837
[TBL] [Abstract][Full Text] [Related]
3. Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: analysis of a family and review of the literature.
Gedicke MM; Traupe H; Fischer B; Tinschert S; Hennies HC
Br J Dermatol; 2006 Jan; 154(1):167-71. PubMed ID: 16403113
[TBL] [Abstract][Full Text] [Related]
4. Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti.
Choate KA; Lu Y; Zhou J; Elias PM; Zaidi S; Paller AS; Farhi A; Nelson-Williams C; Crumrine D; Milstone LM; Lifton RP
J Clin Invest; 2015 Apr; 125(4):1703-7. PubMed ID: 25774499
[TBL] [Abstract][Full Text] [Related]
5. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination.
Kiritsi D; He Y; Pasmooij AM; Onder M; Happle R; Jonkman MF; Bruckner-Tuderman L; Has C
J Clin Invest; 2012 May; 122(5):1742-6. PubMed ID: 22466645
[TBL] [Abstract][Full Text] [Related]
6. A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.
van den Akker PC; Pasmooij AMG; Joenje H; Hofstra RMW; Te Meerman GJ; Jonkman MF
PLoS One; 2018; 13(2):e0192994. PubMed ID: 29470523
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal inversions as a hidden disease-modifying factor for somatic recombination phenotypes.
Nomura T; Suzuki S; Miyauchi T; Takeda M; Shinkuma S; Fujita Y; Nishie W; Akiyama M; Shimizu H
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563344
[TBL] [Abstract][Full Text] [Related]
8. Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.
Jongmans MC; Verwiel ET; Heijdra Y; Vulliamy T; Kamping EJ; Hehir-Kwa JY; Bongers EM; Pfundt R; van Emst L; van Leeuwen FN; van Gassen KL; Geurts van Kessel A; Dokal I; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
Am J Hum Genet; 2012 Mar; 90(3):426-33. PubMed ID: 22341970
[TBL] [Abstract][Full Text] [Related]
9. Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism.
Miyauchi T; Suzuki S; Takeda M; Peh JT; Aiba M; Natsuga K; Fujita Y; Takeichi T; Sakamoto T; Akiyama M; Shimizu H; Nomura T
Am J Hum Genet; 2021 Jun; 108(6):1026-1039. PubMed ID: 34004138
[TBL] [Abstract][Full Text] [Related]
10. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.
Jonkman MF; Scheffer H; Stulp R; Pas HH; Nijenhuis M; Heeres K; Owaribe K; Pulkkinen L; Uitto J
Cell; 1997 Feb; 88(4):543-51. PubMed ID: 9038345
[TBL] [Abstract][Full Text] [Related]
11. A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma.
Song S; Shen C; Song G; Mao X; Yan G; Wang X; Yan M; Zhong N
Br J Dermatol; 2008 Sep; 159(3):714-9. PubMed ID: 18844868
[TBL] [Abstract][Full Text] [Related]
12. Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex.
Schuilenga-Hut PH; Scheffer H; Pas HH; Nijenhuis M; Buys CH; Jonkman MF
J Invest Dermatol; 2002 Apr; 118(4):626-30. PubMed ID: 11918708
[TBL] [Abstract][Full Text] [Related]
13. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
Pasmooij AM; Garcia M; Escamez MJ; Nijenhuis AM; Azon A; Cuadrado-Corrales N; Jonkman MF; Del Rio M
J Invest Dermatol; 2010 Oct; 130(10):2407-11. PubMed ID: 20574443
[TBL] [Abstract][Full Text] [Related]
14. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis.
Korge BP; Ishida-Yamamoto A; Pünter C; Dopping-Hepenstal PJ; Iizuka H; Stephenson A; Eady RA; Munro CS
J Invest Dermatol; 1997 Oct; 109(4):604-10. PubMed ID: 9326398
[TBL] [Abstract][Full Text] [Related]
15. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.
Pasmooij AM; Pas HH; Bolling MC; Jonkman MF
J Clin Invest; 2007 May; 117(5):1240-8. PubMed ID: 17476356
[TBL] [Abstract][Full Text] [Related]
16. Two novel mutations in the LOR gene in three families with loricrin keratoderma.
Hotz A; Bourrat E; Hausser I; Haftek M; da Silva MV; Fischer J
Br J Dermatol; 2015 Apr; 172(4):1158-62. PubMed ID: 25234742
[No Abstract] [Full Text] [Related]
17. Revertant mosaicism in skin: natural gene therapy.
Lai-Cheong JE; McGrath JA; Uitto J
Trends Mol Med; 2011 Mar; 17(3):140-8. PubMed ID: 21195026
[TBL] [Abstract][Full Text] [Related]
18. Revertant mosaicism repairs skin lesions in a patient with keratitis-ichthyosis-deafness syndrome by second-site mutations in connexin 26.
Gudmundsson S; Wilbe M; Ekvall S; Ameur A; Cahill N; Alexandrov LB; Virtanen M; Hellström Pigg M; Vahlquist A; Törmä H; Bondeson ML
Hum Mol Genet; 2017 Mar; 26(6):1070-1077. PubMed ID: 28158657
[TBL] [Abstract][Full Text] [Related]
19. Revertant mosaicism in the skin.
Lai-Cheong JE; McGrath JA
G Ital Dermatol Venereol; 2013 Feb; 148(1):73-82. PubMed ID: 23407079
[TBL] [Abstract][Full Text] [Related]
20. Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.
Azzollini J; Pesenti C; Ferrari L; Fontana L; Calvello M; Peissel B; Portera G; Tabano S; Carcangiu ML; Riva P; Miozzo M; Manoukian S
PLoS One; 2017; 12(2):e0171663. PubMed ID: 28199346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
